# HIV Antibody Increases Following Viral Rebound in People Receiving Antiretroviral Therapy

> **NCT07665060** · — · ACTIVE_NOT_RECRUITING · sponsor: **NYU Langone Health** · enrollment: 6100 (estimated)

## Conditions studied

- HIV

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07665060
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2031-03-31
- **Final completion:** 2031-03-31
- **Target enrollment:** 6100 (ESTIMATED)
- **Last updated:** 2026-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07665060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07665060, "HIV Antibody Increases Following Viral Rebound in People Receiving Antiretroviral Therapy". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07665060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
